Giant basaloid squamous cell carcinoma of the left face: a case report

doi:10.19438/j.cjoms.2022.05.019

Abstract

Abstract: Basaloid squamous cell carcinoma is a special subtype of squamous cell carcinoma. It is rare in clinic, especially in oral and maxillofacial skin. This paper reported a 57-year-old male patient with ulceration of the left face. Clinical examination found a large area of skin ulceration on the left face. The pathological diagnosis after biopsy was basaloid squamous cell carcinoma. After extensive resection of the tumor under general anesthesia, the defect was repaired with forearm free flap, followed by radiotherapy. Twelve months after operation, the patient was alive with no evidence of disease. Based on review of relevant literatures, the clinical characteristics, risk factors, tissue origin, diagnosis, differential diagnosis, treatment and prognosis of basaloid squamous cell carcinoma were analyzed.

Key words: Maxillofacial skin, Squamous cell carcinoma, Basaloid squamous cell carcinoma

CLC Number:

R739.8

ZHOU Yan-yan, LIU Li, JIN Wu-long. Giant basaloid squamous cell carcinoma of the left face: a case report[J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 517-520.

References

[1] Chernock RD, Lewis JS Jr, Zhang Q, et al.Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma[J]. Hum Pathol, 2010, 41(7): 1016-1023.
[2] 崔力方, 昌红, 赵洪禹, 等. 喉基底样鳞状细胞癌中人乳头瘤病毒及细胞周期相关蛋白的表达[J]. 中华病理学杂志, 2018, 47(9): 682-686.
Cui LF, Chang H, Zhao HY, et al.Significance of HPV and cell cycle related proteins in basaloid squamous cell carcinoma of the larynx[J]. Chin J Pathol, 2018, 47(9): 682-686.
[3] Wain SL, Kier R,Vollmer RT, et al.Basaloid squamous cell carcinoma of the tongue, hypopharynx and larynx: report of 10 cases[J]. Hum Pathol, 1986, 17(11): 1158-1166.
[4] Barnes L, Evenson JW, Reichart P, et al.Pathology and genetics, head and neck tumours[A]//World Health Organization classification of tumours[M]. Lyon: IARC Press, 2005: 124-125.
[5] Boyd AS, Rapini RP.Cutaneous collision tumors. An analysis of 69 cases and review of the literature[J]. Am J Dermatopathol, 1994, 16(3):253-257.
[6] Mckay MJ, Bilous AM.Basaloid-squamous carcinoma of the hypopharynx[J]. Cancer, 1989, 63(12): 2528-2531.
[7] Cho KJ, Jeong SU, Kim SB, et al.Basaloid squamous cell carcinoma of the head and neck: subclassication into basal, ductal, and mixed subtypes based on comparison of clinic-pathologic features and expression of p53, cyclin D1, epidermal growth factor receptor, p16, and human papillomavirus[J]. J Pathol Transl Med, 2017, 51(4): 374-380.
[8] 代璐岭, 杨秀秀, 赵好为, 等. 牙龈基底细胞样鳞状细胞癌1例[J]. 华西口腔医学杂志, 2020,38(3): 343-346.
Dai LL, Yang XX, Zhao HW, et al.Basaloid squamous cell carcinoma in gingiva: a case report[J]. West China Journal of Stomatology,2020,38(3):347-350.
[9] Jumaily M, Faraji F, Zhang D, et al.Basaloid squamous cell carcinoma of the larynx: a national cancer database analysis[J]. Otolaryngol Head Neck Surg, 2019, 160(5): 847-854.
[10] Winzenburg SM, Niehans GA, Evan G, et al.Basaloid squamous carcinoma: a clinical comparison of two histologic types with poorly differentiated squamous cell carcinoma[J]. Otolaryngol Head Neck Surg, 1998, 119(5): 471-475.
[11] 赵磊, 初霞, 李珊珊, 等. 食管基底细胞样鳞癌组织 Ki-67表达水平及意义[J]. 人民军医, 2021,64(5): 446-449.
Zhao L, Chu X, Li SS, et al.Expression and significance of Ki-67 in basaloid squamous cell carcinoma of esophagus[J]. People’s Military Surgeon,2021,64(5): 446-449.

[1]	HAN Lin-zi, ZHOU Jian-hua, ZHAO Qian, DONG Lei, CHEN Zheng-gang, QIU Jian-zhong, YUAN Rong-tao. The regulation and mechanism of cancer-associated fibroblasts on tumor-infiltrating immune cells in head and neck squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 119-124.
[2]	LIU Jiang-long, JIA Fang, WANG Xiao-rong, REYILAI Abudukeremu, WUERGULI Alifu, MAIMAITITUXUN Tuerdi. Diagnostic value of contrast-enhanced ultrasound in cervical lymph node metastasis from oral and maxillofacial squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 168-174.
[3]	REZIWANGULI·Yasen, MAIREPATI·Maiming, LI Chen-xi, GONG Zhong-cheng. Research progress in the role and mechanism of Porphyromonas gingivalis in promoting oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 186-190.
[4]	LAN Rong, RUAN Min, HAN Nan-nan, WANG Feng. Peri-implant squamous cell carcinoma appeared after implant-restoration in the left mandible: a case report [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 203-205.
[5]	LI Xue-er, WANG Zheng-ye, TUERDI Maimaitituxun. Identification of HPV status in head and neck squamous cell carcinoma patients based on radiomics: diagnostic meta-analysis [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 69-74.
[6]	LIU Heng, DUAN Xiao-feng. Research progress of ferritinophagy and related genes FTH1 and NCOA4 in oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 87-91.
[7]	ZHOU Yu, WENG Hai-yan, SI Cheng-yun, DUAN Xian-jie, AN Xing-fei, ZHANG Li-yu. Clinical study on the prognostic and risk stratification effect of the 8th revised TNM staging on patients with early oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(6): 571-576.
[8]	YANG Hui-li, WANG Yu-fan, WANG Feng, SHEN Yue-hong, YANG Hong-yu. Comprehensive co-expression analysis revealed NLRP1 as a prognostic immune-associated gene in head and neck squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 429-436.
[9]	JI Ping-ping, LI Li, WU Yi-fan, HOU Li-li. Effect of transcutaneous electrical acupoint stimulation on myelosuppression in patients with oral squamous cell carcinoma after induction chemotherapy [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 455-460.
[10]	XU Gang, SONG Qi-yi, JIANG Wei-dong, LIU Jing-xiu. Expression and clinical significance of aquaporin 3 in oral mucosal epithelial dysplasia and oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 478-482.
[11]	WANG Chong, KANG Xin-dan, WANG Rui, WU Ya-ping, SUN Lu-lu, ZHANG Zhi-yuan, SUN Shu-yang. Establishment and identification of patient-derived organoid model in head and neck squamous carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 328-333.
[12]	LI Heng-yong, YANG Song, ZHOU Kai, KONG Yu, LI Jie-ying, LI Gui-zhong, GE Sheng-you, YANG Xiao-chen, FENG Yuan-yong, SONG Kai, SHANG Wei. Survival analysis of 336 patients with HPV-mediated and non-mediated oropharyngeal squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 378-383.
[13]	YANG Song, WANG Ning, ZHAO Shu-chao, LI Heng-yong, GE Sheng-you, ZHOU Kai, SONG Kai, SHANG Wei, FENG Yuan-yong. Expression and clinical significance of chemerin in oral squamous cell carcinoma patients combined with type 2 diabetes [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 390-395.
[14]	ZHANG Yi-yi, YANG Yue-yi, JU Wu-tong, ZHONG Lai-ping. Neoadjuvant immunotarget therapy in patients with locally advanced oral squamous cell carcinoma: report of 2 cases and literature review [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 413-416.
[15]	WEI Dong-liang, LI Zhi, JU Hou-yu, WU Yun-teng, GUO Wei, REN Guo-xin. Mechanism of EGFR-targeted drugs for pain relief in oral cancer [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(3): 219-224.